National Payer Strategy & Accounts Lead

Algernon Group; Princeton (NJ); Hybrid; USD 180,000 - 240,000; Full time

Job summary

Cartesian Therapeutics, a clinical-stage biotechnology company, seeks a National Lead Strategic Payer Accounts to lead national and regional payer engagement and contracting for upcoming launches. You will translate access strategy into field execution, while building a NAM team and shaping coverage, reimbursement, and access to maximize patient access.

Ideal candidates have 10–15 years in biopharma payer roles, deep U.S. payer expertise, and a track record with first-in-class therapies.

Qualifications

• Progressive biopharma experience with payer account management and market access.
• Strong leadership with ability to manage cross-functional teams.
• Deep knowledge of U.S. payer and reimbursement landscape, including government and commercial payers.

Responsibilities

• Build and maintain senior-level payer relationships at national and regional levels.
• Lead payer negotiations and contracting aligned to strategy.
• Operationalize access strategy in field with brand value and evidence.
• Engage payers early to shape access and generate pricing insights.
• Deliver payer value narratives supported by clinical, economic, and real-world data.
• Collaborate with commercial and medical teams for aligned payer strategy.
• Hire and mentor NAM team; drive accountable, high-impact engagement.
• Synthesize payer insights to refine pricing, contracting, and access plans.
• Support pre-launch readiness and coverage strategies for launch.

Skills

Biopharma

Payer Management

Market Access

Strategic Leadership

Contracting

Education

Bachelor's degree

MBA or PharmD preferred

Job description

Cartesian Therapeutics, a clinical-stage biotechnology company, seeks a National Lead Strategic Payer Accounts to lead national and regional payer engagement and contracting for upcoming launches. You will translate access strategy into field execution, while building a NAM team and shaping coverage, reimbursement, and access to maximize patient access.

Ideal candidates have 10–15 years in biopharma payer roles, deep U.S. payer expertise, and a track record with first-in-class therapies.